Highlights:
– Nearly a dozen cultivated meat companies folded between 2024 and 2025 as venture capital dried up and production costs stayed stubbornly high.
– At least seven U.S. states have banned or restricted cultivated meat sales, creating a fragmented regulatory landscape that chokes investment.
– Hybrid products—mostly plant protein with a small dash of cultivated cells—may be the only commercially viable path forward.
I remember the pitch vividly. A few years ago, every food-tech conference I attended had the same slide: a gleaming bioreactor, a promise to slash agricultural emissions by 90%, and a timeline that put affordable lab-grown steak on my plate by 2025. The room always applauded.
Last week, I walked through an empty exhibit hall in Chicago where one of those same startups had planned to showcase its cultivated chicken. The company, Believer Meats, had already shut down by then, quietly dissolving after failing to secure last-minute funding despite holding U.S. regulatory approval. It wasn’t alone. Meatable, a Dutch pioneer, dissolved in December. SCiFi Foods ran out of money in 2024. Upstream Foods wound down. The casualty list keeps growing.
What happened isn’t a mystery to anyone who followed the money. Cultivated meat companies raised just $73.9 million in 2025, down from $144 million the year before—a rounding error compared to the billions flowing into AI or even conventional food tech. The technology works, in the sense that you can grow animal cells in a tank. But making that affordable at scale has proven brutally difficult. The culture media alone accounts for most of the environmental impact and cost, and serum-free alternatives remain expensive. Aleph Farms, one of the survivors, now sells a “steak” that is only 10-20% cultivated cells, padded out with soy and wheat protein. That’s not the future we were promised. It’s a pragmatic retreat.
Then came the political backlash. Florida banned sales outright. Alabama, Texas, Montana, and Mississippi followed. By the end of 2025, seven states had bans in effect, with more considering labeling restrictions so stringent they’d function as de facto prohibitions. The rhetoric from agricultural lobbies framed cultivated meat as a threat to ranchers, never mind that most farmers surveyed were more worried about labor shortages and disease than lab-grown competition.
I still think the original vision had merit. Food security, reduced land use, fewer antibiotics—these are real problems. But the industry sold a revolution and delivered a science project. The survivors are now talking about “complementary proteins” and hybrid blends, which is honest but far less inspiring. The world wasn’t saved. It wasn’t even changed much. And the bioreactors, for now, sit idle.
